Efficacy of 24-Hour Blood Pressure Monitoring in Evaluating Response to Percutaneous Transluminal Renal Angioplasty

Purpose It is currently controversial whether renal artery stenting is beneficial for the clinical outcomes of atherosclerotic renal artery stenosis (ARAS) patients. The study aims to evaluate whether blood pressure (BP) and renal function improve in ARAS patients after stenting. Methods A retrospective study was conducted on 78 ARAS patients who underwent renal artery stenting at the First Affiliated Hospital of Chongqing Medical University from January 2013 to June 2024. BP, the number of oral antihypertensive medications, renal function, and adverse events were analyzed before and after stenting. Results A total of 90 stents were implanted. The median follow-up time was 1.59 years. From 24 hours post-operation, significant decline in BP were observed. During follow-up, systolic BP decreased by 24.27 mmHg (95% CI: 16.54–32.00; P < 0.0001) and diastolic BP by 12.27 mmHg (95% CI: 7.25–17.29; P < 0.0001), but the reduction in the number of oral antihypertensive medications was not significant ( P > 0.05). Serum creatinine also showed a significant decrease of 8.50 μmol/L at follow-up ( P < 0.05). Among the four subgroups, 30 patients with mild renal impaired [eGFR ≥ 60 mL/(min·1.73 m2) and <90 mL/(min·1.73 m2)] showed an increase of 10.68 mL/(min·1.73 m2) in eGFR during follow-up ( P < 0.01), while the eGFR of the remaining 48 patients with other renal function stages showed no significant change before and after stenting. Moreover, 24 patients experienced cardiovascular or/and renal adverse events. Conclusions Renal artery stenting might significantly reduce BP and improve renal function in ARAS patients, particularly those with mild renal impairment, which still requires prospective multicenter studies to confirm.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Efficacy of 24-Hour Blood Pressure Monitoring in Evaluating Response to Percutaneous Transluminal Renal Angioplasty

Cited by 5 publications

References 41 publications

How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?

How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?

Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease‐Induced Resistant Hypertension: Further Considerations for 24‐Hour Blood Pressure Profiles

Evaluation of the therapeutic efficacy of renal artery stenting in patients with atherosclerotic renal artery stenosis

Contact Info

Product

Resources

About